HAO1 gene editing therapeutic(Precision BioSciences)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameHAO1 gene editing therapeutic(Precision BioSciences)
Drug Alias NameN/A
ClassificationCell and gene therapy > Gene therapyBiologics > Protein drugs > Enzyme
Mechanisms of ActionGene expression modulators
TargetsNot applicable
Therapy Area/IndicationsHyperoxaluria, Primary
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesPrecision Biosciences Inc
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsHyperoxaluria, Primary
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A